Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Matinas BioPharma Holdings, Inc. (MTNB) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
Docs: "Matinas BioPharma Holdings, Inc. Condensed Consolidated Balance Sheets June 30, 2023 December 31, 2022 ASSETS: Current assets: Cash and cash equivalents $ 9,743 $ 6,830 Marketable debt securities 12,770 21,933 Restricted cash – security deposit 50 50 Prepaid expenses and other current assets 1,437 5,719 Total current assets 24,000 34,532 Non-current assets: Leasehold improvements and equipment – net 2,103 2,091 Operating lease right-of-use assets – net 3,345 3,613 Finance lease right-of-use assets – net 24 30 In-process research and development 3,017 3,017 Goodwill 1,336 1,336 Restricted cash – security deposit 200 200 Total non-current assets 10,025 10,287 Total assets $ 34,025 $ 44,819 LIABILITIES AND STOCKHOLDERS’ EQUITY: Current liabilities: Accounts payable $ 604 $ 618 Accrued expens..."
03/15/2023 8-K Quarterly results
Docs: "Matinas BioPharma Holdings, Inc. Consolidated Balance Sheets December 31, 2022 2021 ASSETS: Current assets: Cash and cash equivalents $ 6,830 $ 21,030 Marketable debt securities 21,933 28,592 Restricted cash – security deposit 50 50 Prepaid expenses and other current assets 5,719 1,321 Total current assets 34,532 50,993 Non-current assets: Leasehold improvements and equipment - net 2,091 1,538 Operating lease right-of-use assets - net 3,613 4,219 Finance lease right-of-use assets - net 30 23 In-process research and development 3,017 3,017 Goodwill 1,336 1,336 Restricted cash - security deposit 200 200 Total non-current assets 10,287 10,333 Total assets $ 44,819 $ 61,326 LIABILITIES AND STOCKHOLDERS’ EQUITY: Current liabilities: Accounts payable $ 618 $ 937 Accrued expenses and other liabil..."
08/11/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
03/08/2022 8-K Quarterly results
11/08/2021 8-K Quarterly results
Docs: "Matinas BioPharma Reports Third Quarter 2021 Financial Results and Operational Highlights"
05/10/2021 8-K Quarterly results
03/29/2021 8-K Quarterly results
11/06/2020 8-K Quarterly results
Docs: "Source: Matinas BioPharma Holdings, Inc."
08/10/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
Docs: "Source: Matinas BioPharma Holdings, Inc."
03/09/2020 8-K Quarterly results
08/13/2019 8-K Investor presentation, Quarterly results
Docs: "Matinas BioPharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update",
"Presentation"
05/14/2019 8-K Quarterly results
Docs: "Matinas BioPharma Provides Corporate Update and Reports First Quarter 2019 Financial Results"
04/02/2019 8-K Quarterly results
Docs: "Matinas BioPharma Reports 2018 Financial Results and Provides Corporate Update"
08/08/2017 8-K Quarterly results
Docs: "Matinas BioPharma Reports 2017 Second Quarter Financial Results and Reaffirms Clinical and Regulatory Strategy to Advance MAT2203 and MAT2501"
04/03/2017 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy